This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Identify bond funds that offer tax-exempt income in retirement and how to incorporate them for tax-efficient withdrawals.
23,934 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
MP Materials is catching attention from large buyers of stock as it moves to boost magnet production and solidify the...
A Reuters briefing this week reignited the debate over Banksy’s anonymity and its effect on art values, prompting a r...
When a juggernaut like Fortnite cools its engagement, the ripple effect hits the entire company. This piece digs into...
The Invesco QQQM ETF offers a low-cost way to ride tech gains, but a handful of mega-caps shape most of its outcomes,...
Disney faces a growing disney narrative problem wall as Wall Street questions leadership, strategy, and long-term pro...
Goldman Sachs' latest research paints a paradox: trillions are pouring into AI infrastructure, but returns remain mur...
Amphastar delivered a careful Q1 2026 showing steady revenue momentum and margin discipline. This guide breaks down t...
Paris-based Capital B raises €15.2 million in a private round to buy 182 BTC, expanding its Bitcoin treasury holdings...
Cardano unveils an institutional vault layer designed for tokenized capital on Cardano's chain, signaling a shift awa...
A leading voice in personal finance questions the premise of hitting a $1 million target by age 25, urging young adul...
Coinbase and MicroStrategy’s Strategy stock both fell as investors trimmed exposure to digital asset names amid profi...